These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 30123217)
1. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells. Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS Front Immunol; 2018; 9():1782. PubMed ID: 30123217 [TBL] [Abstract][Full Text] [Related]
2. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922 [TBL] [Abstract][Full Text] [Related]
3. Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis. Dopkins N; Miranda K; Wilson K; Holloman BL; Nagarkatti P; Nagarkatti M J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):15-32. PubMed ID: 34757526 [TBL] [Abstract][Full Text] [Related]
4. Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. Hegde VL; Nagarkatti PS; Nagarkatti M PLoS One; 2011 Apr; 6(4):e18281. PubMed ID: 21483776 [TBL] [Abstract][Full Text] [Related]
5. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung. Glenn JD; Liu C; Whartenby KA J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897 [TBL] [Abstract][Full Text] [Related]
6. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis. Giacoppo S; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E Daru; 2015 Oct; 23():48. PubMed ID: 26489494 [TBL] [Abstract][Full Text] [Related]
7. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways. Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS Front Immunol; 2019; 10():1921. PubMed ID: 31497013 [TBL] [Abstract][Full Text] [Related]
8. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Kozela E; Lev N; Kaushansky N; Eilam R; Rimmerman N; Levy R; Ben-Nun A; Juknat A; Vogel Z Br J Pharmacol; 2011 Aug; 163(7):1507-19. PubMed ID: 21449980 [TBL] [Abstract][Full Text] [Related]
9. NAD+ attenuates experimental autoimmune encephalomyelitis through induction of CD11b+ gr-1+ myeloid-derived suppressor cells. Wang JL; Li B; Tan GJ; Gai XL; Xing JN; Wang JQ; Quan MY; Zhang N; Guo L Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32301489 [TBL] [Abstract][Full Text] [Related]
10. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice. Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis. González-García C; Torres IM; García-Hernández R; Campos-Ruíz L; Esparragoza LR; Coronado MJ; Grande AG; García-Merino A; Sánchez López AJ Exp Neurol; 2017 Dec; 298(Pt A):57-67. PubMed ID: 28867485 [TBL] [Abstract][Full Text] [Related]
12. Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells. Kozela E; Juknat A; Gao F; Kaushansky N; Coppola G; Vogel Z J Neuroinflammation; 2016 Jun; 13(1):136. PubMed ID: 27256343 [TBL] [Abstract][Full Text] [Related]
13. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation. Nichols JM; Kummari E; Sherman J; Yang EJ; Dhital S; Gilfeather C; Yray G; Morgan T; Kaplan BLF J Neuroimmune Pharmacol; 2021 Jun; 16(2):346-362. PubMed ID: 32440886 [TBL] [Abstract][Full Text] [Related]
14. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281 [TBL] [Abstract][Full Text] [Related]
15. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794 [TBL] [Abstract][Full Text] [Related]
16. The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model. Jiang Q; Duan J; Van Kaer L; Yang G Aging Dis; 2024 May; 15(3):1329-1343. PubMed ID: 37307825 [TBL] [Abstract][Full Text] [Related]
17. The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis. Melero-Jerez C; Suardíaz M; Lebrón-Galán R; Marín-Bañasco C; Oliver-Martos B; Machín-Díaz I; Fernández Ó; de Castro F; Clemente D Neurobiol Dis; 2019 Jul; 127():13-31. PubMed ID: 30798007 [TBL] [Abstract][Full Text] [Related]
18. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307 [TBL] [Abstract][Full Text] [Related]